Market Overview:
The global blood transfusion diagnostics market is expected to grow at a CAGR of 7.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing incidence of blood-borne diseases, growing demand for safe and effective blood transfusions, and technological advancements in the field of transfusion diagnostics. The global blood transfusion diagnostics market is segmented on the basis of type, application, and region. On the basis of type, the market is segmented into ELISA assays, NAT assays, Western blot assays, fluorescence assay assays,, and other technology-based assay methods. The ELISA assay segment is expected to account for a major share of the global blood transfusion diagnostics market in 2018 owing to its high accuracy and reliability. In addition,.
Product Definition:
Blood transfusion diagnostics is a medical specialty that deals with the diagnosis of blood disorders, including anemia, hemolysis, thrombocytopenia and leukemia. These disorders can be diagnosed through blood tests, which can help doctors identify the underlying cause of the patient's symptoms and prescribe an appropriate treatment. Blood transfusion diagnostics is important because it helps to ensure that patients receive the correct type of blood transfusion and prevents them from developing potentially life-threatening complications.
ELISA:
ELISA (enzyme-linked immunosorbent assay) is a diagnostic test used for detecting the presence of antibodies in the blood. It also helps to identify diseases and conditions such as hepatitis, AIDS, autoimmune disorders, cancer and other infections like H. influenzae & S. pneumoniae among others by measuring antibody response to their toxins or coat antigens respectively.
NAT:
Network address translation is a technique that maps an entire network of computers with unique IP addresses to one or more physical devices. It allows several hosts with multiple IP addresses to use a single set of network hardware. NAT can be used for various applications such as gaming, internet sharing, and software implementation on home networks among others.
Application Insights:
The market is segmented into hospitals, clinics, blood banks and laboratories. Hospitals held the largest share in 2017 owing to the presence of a large number of transfusion-dependent patients. Moreover, these institutions are engaged in R&D for developing new diagnostic techniques and products for reducing transfusion requirements. This factor is anticipated to fuel product demand over the forecast period.
Blood banks are expected to witness lucrative growth during the study period due to an increase in blood collection and awareness programs related to safe storage conditions of donor blood samples. Furthermore, increasing cross country migrations along with an increase in accidents resulting in increased need for fresh frozen plasma (FFP) & red cells (RBCs) are expected drive segment growth over the forecast period globally as well as regionally speaking.
The other application segment includes pre-transfusion testing, post-transfusion testing.
Regional Analysis:
North America dominated the global blood transfusion diagnostics market in 2017. This can be attributed to the presence of key players, high adoption rate of advanced technologies and increasing demand for efficient healthcare services. The region is expected to maintain its dominance throughout the forecast period owing to continuous technological advancements and growing awareness among people about blood donation.
Asia Pacific is anticipated to witness lucrative growth over the forecast period due to factors such as improving healthcare infrastructure, rising patient awareness levels regarding various available diagnostic techniques, increase in per capita income & disposable income & population growth coupled with government initiatives for promoting voluntary donations at community level. These factors are likely contribute towards increased demand for these tests across this region during the forecast period from 2018-2030 (estimated).
Blood donation has a strong cultural significance in many countries around the world including India, Brazil and China amongst others which have led them into being some of largest donors globally (1).
Growth Factors:
- Increasing incidence of blood disorders and blood transfusion procedures
- Growing demand for minimally invasive blood transfusion procedures
- Technological advancements in Blood Transfusion Diagnostics market
- Rising number of private diagnostic centers and hospitals
- increasing government funding for research and development in Blood Transfusion Diagnostics market
Scope Of The Report
Report Attributes
Report Details
Report Title
Blood Transfusion Diagnostics Market Research Report
By Type
ELISA, NAT, Western Blot Assays, Fluorescence Assay, Other Technology
By Application
Hospitals, Clinics, Blood Banks, Laboratories, Other
By Companies
Grifols, Thermo Fisher Scientific, Roche, bioMérieux, Bio-Rad, Ortho Clinical Diagnostics, Becton Dickinson, Fujirebio, DiaSorin(American Standard Companies), Beckman Coulter, Diagast, Abbott, BAG Health Care, Quidel
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
137
Number of Tables & Figures
96
Customization Available
Yes, the report can be customized as per your need.
Global Blood Transfusion Diagnostics Market Report Segments:
The global Blood Transfusion Diagnostics market is segmented on the basis of:
Types
ELISA, NAT, Western Blot Assays, Fluorescence Assay, Other Technology
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals, Clinics, Blood Banks, Laboratories, Other
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Grifols
- Thermo Fisher Scientific
- Roche
- bioMérieux
- Bio-Rad
- Ortho Clinical Diagnostics
- Becton Dickinson
- Fujirebio
- DiaSorin(American Standard Companies)
- Beckman Coulter
- Diagast
- Abbott
- BAG Health Care
- Quidel
Highlights of The Blood Transfusion Diagnostics Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- ELISA
- NAT
- Western Blot Assays
- Fluorescence Assay
- Other Technology
- By Application:
- Hospitals
- Clinics
- Blood Banks
- Laboratories
- Other
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Blood Transfusion Diagnostics Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Blood transfusion diagnostics is a field of medical science that deals with the diagnosis and treatment of blood disorders.
Some of the major players in the blood transfusion diagnostics market are Grifols, Thermo Fisher Scientific, Roche, bioM©rieux, Bio-Rad, Ortho Clinical Diagnostics, Becton Dickinson, Fujirebio, DiaSorin(American Standard Companies), Beckman Coulter, Diagast, Abbott, BAG Health Care, Quidel.
The blood transfusion diagnostics market is expected to grow at a compound annual growth rate of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Blood Transfusion Diagnostics Market Overview 4.1 Introduction 4.1.1 Market Taxonomy 4.1.2 Market Definition 4.1.3 Macro-Economic Factors Impacting the Market Growth 4.2 Blood Transfusion Diagnostics Market Dynamics 4.2.1 Market Drivers 4.2.2 Market Restraints 4.2.3 Market Opportunity 4.3 Blood Transfusion Diagnostics Market - Supply Chain Analysis 4.3.1 List of Key Suppliers 4.3.2 List of Key Distributors 4.3.3 List of Key Consumers 4.4 Key Forces Shaping the Blood Transfusion Diagnostics Market 4.4.1 Bargaining Power of Suppliers 4.4.2 Bargaining Power of Buyers 4.4.3 Threat of Substitution 4.4.4 Threat of New Entrants 4.4.5 Competitive Rivalry 4.5 Global Blood Transfusion Diagnostics Market Size & Forecast, 2020-2028 4.5.1 Blood Transfusion Diagnostics Market Size and Y-o-Y Growth 4.5.2 Blood Transfusion Diagnostics Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 ELISA
5.2.2 NAT
5.2.3 Western Blot Assays
5.2.4 Fluorescence Assay
5.2.5 Other Technology
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Hospitals
6.2.2 Clinics
6.2.3 Blood Banks
6.2.4 Laboratories
6.2.5 Other
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Blood Transfusion Diagnostics Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Blood Transfusion Diagnostics Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 ELISA
9.6.2 NAT
9.6.3 Western Blot Assays
9.6.4 Fluorescence Assay
9.6.5 Other Technology
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Hospitals
9.10.2 Clinics
9.10.3 Blood Banks
9.10.4 Laboratories
9.10.5 Other
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 ELISA
10.6.2 NAT
10.6.3 Western Blot Assays
10.6.4 Fluorescence Assay
10.6.5 Other Technology
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Hospitals
10.10.2 Clinics
10.10.3 Blood Banks
10.10.4 Laboratories
10.10.5 Other
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 ELISA
11.6.2 NAT
11.6.3 Western Blot Assays
11.6.4 Fluorescence Assay
11.6.5 Other Technology
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Hospitals
11.10.2 Clinics
11.10.3 Blood Banks
11.10.4 Laboratories
11.10.5 Other
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 ELISA
12.6.2 NAT
12.6.3 Western Blot Assays
12.6.4 Fluorescence Assay
12.6.5 Other Technology
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Hospitals
12.10.2 Clinics
12.10.3 Blood Banks
12.10.4 Laboratories
12.10.5 Other
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 ELISA
13.6.2 NAT
13.6.3 Western Blot Assays
13.6.4 Fluorescence Assay
13.6.5 Other Technology
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Hospitals
13.10.2 Clinics
13.10.3 Blood Banks
13.10.4 Laboratories
13.10.5 Other
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Blood Transfusion Diagnostics Market: Competitive Dashboard
14.2 Global Blood Transfusion Diagnostics Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Grifols
14.3.2 Thermo Fisher Scientific
14.3.3 Roche
14.3.4 bioMérieux
14.3.5 Bio-Rad
14.3.6 Ortho Clinical Diagnostics
14.3.7 Becton Dickinson
14.3.8 Fujirebio
14.3.9 DiaSorin(American Standard Companies)
14.3.10 Beckman Coulter
14.3.11 Diagast
14.3.12 Abbott
14.3.13 BAG Health Care
14.3.14 Quidel